Zenas BioPharma, Inc. (ZBIO)
27.48
-2.16
(-7.27%)
USD |
NASDAQ |
Sep 24, 16:00
27.48
0.00 (0.00%)
After-Hours: 19:59
Zenas BioPharma Price : 27.48 for Sept. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 23, 2026 | 33.09 | 33.09 | 29.53 | 29.63 | 525138.0 |
| Sep 22, 2026 | 32.55 | 33.84 | 32.15 | 33.05 | 452811.0 |
| Sep 21, 2026 | 31.62 | 33.19 | 31.00 | 32.55 | 414502.0 |
| Sep 18, 2026 | 32.04 | 32.04 | 31.25 | 31.50 | 2.515M |
| Sep 17, 2026 | 32.78 | 33.48 | 31.55 | 31.97 | 527843.0 |
| Sep 16, 2026 | 31.89 | 33.23 | 31.58 | 32.32 | 746409.0 |
| Sep 15, 2026 | 32.06 | 32.06 | 30.27 | 31.93 | 715982.0 |
| Sep 14, 2026 | 31.00 | 32.00 | 30.66 | 31.91 | 634641.0 |
| Sep 11, 2026 | 31.48 | 32.32 | 31.12 | 31.12 | 421701.0 |
| Sep 10, 2026 | 31.88 | 31.89 | 30.73 | 31.10 | 646938.0 |
| Sep 09, 2026 | 33.02 | 33.52 | 32.08 | 32.29 | 385382.0 |
| Sep 08, 2026 | 32.65 | 33.84 | 32.30 | 33.05 | 441202.0 |
| Sep 04, 2026 | 32.66 | 33.29 | 32.38 | 32.88 | 452691.0 |
| Sep 03, 2026 | 33.42 | 33.66 | 32.36 | 32.92 | 515117.0 |
| Sep 02, 2026 | 32.21 | 33.40 | 31.93 | 33.13 | 757494.0 |
| Sep 01, 2026 | 32.20 | 32.73 | 31.55 | 31.98 | 432254.0 |
| Aug 31, 2026 | 31.51 | 32.77 | 29.88 | 32.32 | 527682.0 |
| Aug 28, 2026 | 32.27 | 32.38 | 31.19 | 31.27 | 439142.0 |
| Aug 27, 2026 | 32.81 | 33.69 | 32.38 | 32.62 | 658973.0 |
| Aug 26, 2026 | 33.80 | 33.99 | 31.91 | 33.04 | 651577.0 |
| Aug 25, 2026 | 32.00 | 33.78 | 31.64 | 33.77 | 633584.0 |
| Aug 24, 2026 | 32.40 | 32.48 | 30.95 | 31.65 | 481882.0 |
| Aug 21, 2026 | 31.83 | 32.79 | 31.45 | 32.29 | 808719.0 |
| Aug 20, 2026 | 30.72 | 32.20 | 29.50 | 31.62 | 1.173M |
| Aug 19, 2026 | 32.80 | 32.89 | 30.92 | 31.25 | 2.703M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 22.20 |
| Alnylam Pharmaceuticals, Inc. | 249.62 |
| Anika Therapeutics, Inc. | 20.28 |
| Savara, Inc. | 5.075 |
| Vericel Corp. | 39.30 |
Price Related Metrics
| PS Ratio | 1424.51 |
| PEG Ratio | -0.0224 |
| Price to Book Value | 7.042 |
| Earnings Yield | -35.00% |
| Market Cap | 1.740B |
| PEGY Ratio | -0.0224 |